Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Trevi Therapeutics, Inc. (TRVI) had Return on Equity of -6.20% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-12.30M |
|
-- |
|
-- |
|
$13.72M |
|
$-13.72M |
|
$1.40M |
|
$-12.32M |
|
$-12.32M |
|
$-12.30M |
|
$-12.30M |
|
$-12.30M |
|
$-12.30M |
|
$-13.72M |
|
$-13.68M |
|
130.35M |
|
130.35M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$207.23M |
|
$0.24M |
|
$1.11M |
|
$208.34M |
|
$9.24M |
|
-- |
|
$0.60M |
|
$9.85M |
|
$198.49M |
|
$198.49M |
|
$198.49M |
|
121.78M |
|
| Cash Flow Statement Financials | |
$-23.58M |
|
$-12.56M |
|
$119.10M |
|
$34.10M |
|
$117.06M |
|
$82.96M |
|
$2.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-6.20% |
-6.20% |
|
-5.90% |
|
-6.20% |
|
$1.63 |
|
$-0.18 |
|
$-0.18 |
|